Frost & Sullivan Lauds Philips Healthcare’s Introduction of Vereos, the First Digital PET/CT Solution

— Vereos PET/CT is an improvement over PET imaging in quantification accuracy and reproducibility, as well as in procedure workflow efficiency

MOUNTAIN VIEW, Calif., Nov. 26, 2014 /PRNewswire/ — Based on its recent analysis of the positron emission tomography (PET) imaging industry, Frost & Sullivan recognizes Philips Healthcare with the 2014 North America Frost & Sullivan Award for Technology Innovation Leadership. Philips Healthcare launched the industry’s first digital PET/computed tomography (CT) system when it introduced the Vereos PET/CT system. Vereos’s all-digital imaging chain was redesigned from the ground-up, forming a new digital system that aids the next level of performance in PET imaging.

At the core of the Vereos system are novel silicon photomultiplier detectors, which overcome the limitations of avalanche photodiodes (heating and vibrations) to provide a definitive replacement option for traditional analog detectors. This breakthrough innovation is set to enable providers to breach the next frontier in the clinical utility of PET imaging.

Expectedly, digital PET imaging is already experiencing early adoption in academic and research centers. Digital PET imaging’s value proposition of better workflow, performance and reliability is increasingly appealing to facilities looking to scale up their competitive positioning in diagnostic imaging in general and in specialty areas in particular.

Frost & Sullivan believes that while the time-of-flight (TOF) technology facilitated significant enhancements to oncology PET imaging, it made only marginal improvements to cardiology and neurology PET imaging, which are expected to be dynamic growth segments for PET imaging in the next few years, with clinical advances and new radiopharmaceuticals to augment adoption and procedure volume in these two areas.

"Through a combination of hardware and software advances, the Vereos PET/CT offers superior sensitivity and volumetric resolution, which can potentially translate to much richer image quality, performance, reliability and diagnostic confidence in PET imaging," said Frost & Sullivan Principal Analyst Nadim Michel Daher.

With the rise of value-based healthcare and imaging, the patient outcomes generated by advanced and expensive imaging procedures are being all the more scrutinized by health systems and payers. Therefore, it is important for imaging providers vested in molecular imaging to demonstrate PET imaging’s effectiveness in deriving definitive diagnoses and treatment plans.

"However, the importance of digital PET technology goes well beyond its technology, and competitive and business excellence," noted Daher. "Philips’s powerful and meaningful new technology is playing a huge part in bringing diagnostic imaging back to the forefront of the healthcare value chain."

Given the clinical, operational, and financial benefits of the Vereos PET/CT system, it is no surprise that it is being considered the most trusted solution to advance.

Each year, Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing and leveraging new technologies, which significantly impacts both the functionality and the customer value of the new products and applications. The award lauds the high R&D spend toward innovation, its relevance to the industry and the positive impact on brand perception.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About Royal Philips:

Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 115,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation


Mireya Espinoza
P: +1 210.247.3870
F: +1 210.348.1003

Leave a Reply